Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 30, 2018
PolarityTE to Present at the Jefferies 2018 Global Healthcare Conference
SALT LAKE CITY, May 30, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) today announced it will present at the Jefferies 2018 Global Healthcare Conference on ...
May 30, 2018
RedHill Biopharma to Present Positive Phase II Results of BEKINDA® for IBS-D at Digestive Disease Week 2018
TEL-AVIV, Israel and RALEIGH, N.C., May 30, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company ...
May 30, 2018
AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (AZRX) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies ...
May 30, 2018
Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018
WALTHAM, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat ...
May 29, 2018
Pfenex Announces Closing of Public Offering of 7,820,000 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares
SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression ...
May 29, 2018
Kuros Biosciences Announces Start of Investigator-Led Study of MagnetOs Granules for Maxillary Sinus Floor Elevation
SCHLIEREN (ZURICH), Switzerland, May 29, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) announced today the start of an investigator-led study at University Medical Center (UMC) ...
May 29, 2018
Theravance Biopharma Highlights Submission of Regulatory Application in Japan for Once-Daily Single Inhaler Triple Therapy FF/UMEC/VI for Patients with COPD
DUBLIN, May 29, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (TBPH) ("Theravance Biopharma") today highlighted that a regulatory application for once-daily fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI 100/62.5/25 mcg) ...
May 29, 2018
CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 29, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
May 29, 2018
STRATA Skin Sciences Announces Closing of a $17 Million Equity Financing and the Formal Appointment of New Management to Accelerate Growth and Enrich its XTRAC® Business Strategy
HORSHAM, Pa., May 29, 2018 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
May 29, 2018
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the leader in the field of stapled peptide therapeutics for cancers and other diseases, ...
May 29, 2018
Brainsway Reports Record Financial Results for First Quarter of 2018 and Provides Corporate Update
HACKENSACK, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Brainsway Ltd. (BRIN.TA), a leader in the advanced non-invasive treatment of brain disorders, today announced the Company’s ...
May 29, 2018
BioTime Announces $1.9 Million Grant for Continued Development of OpRegen® for Dry-AMD
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, has been awarded a new grant for 2018 of up ...
May 29, 2018
Aimmune Therapeutics Announces Data on Terminology Used with Oral Immunotherapy Were Presented at EAACI 2018
BRISBANE, Calif. & MUNICH, Germany--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that data on terminology ...
May 29, 2018
PolarityTE to host Key Opinion Leader Summit
SALT LAKE CITY, May 29, 2018 (GLOBE NEWSWIRE) -- PolarityTE™, Inc. (COOL) today announced it will host a breakfast event in New York City with ...
May 29, 2018
RedHill Biopharma Announces New U.S. Patent for its Experimental Ebola Therapy
TEL-AVIV, Israel and RALEIGH, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical ...
May 29, 2018
Albireo to Present at Jefferies 2018 Global Healthcare Conference
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
May 29, 2018
UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference
RA’ANANA, Israel and NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
May 29, 2018
Opiant Pharmaceuticals to Participate in The American Society of Clinical Psychopharmacology 2018 Annual Meeting
SANTA MONICA, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced ...
May 29, 2018
FDA Clears Development Pathway for NexoBrid® for Sulfur Mustard Injuries
YAVNE, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
May 29, 2018
Spring Bank to Present at Jefferies 2018 Global Healthcare Conference
HOPKINTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
Page 78 of 158